Weight Loss Management
Elevated Weight Management, Guided by Science.
Regenova offers provider‑guided GLP‑1 and non‑GLP‑1 programs with personalized protocols designed to support consistent habits and help you make meaningful progress. Each plan is tailored to your needs, focusing on responsible treatment options, structured routines, and clear guidance to help you maximize results safely.
BMI Assessment
This metric is a general screening tool and not a medical diagnosis.
Know your Numbers
Your Body Mass Index (BMI) offers a quick snapshot of how your weight relates to your height. It’s a simple starting point for understanding your baseline health and identifying whether you may benefit from weight optimization or metabolic support.
Featured Products
Semaglutide
Tirzepatide
Important Safety and Information and Common Side Effects
Semaglutide is a GLP-1 receptor agonist designed to support appetite regulation, blood sugar balance, and weight management. By mimicking naturally occurring GLP-1 hormones, Semaglutide may help reduce hunger signals, improve satiety, and support sustainable metabolic health goals.
Semaglutide
Potential benefits may include:
Appetite control
Reduced food cravings
Weight management support
Improved metabolic balance
Support for healthy blood sugar regulation
Potential Side Effects may include:
Nausea (most common, especially early)
Decreased appetite
Constipation or diarrhea
Fatigue
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist developed to support advanced metabolic and weight management goals. By targeting multiple metabolic pathways, tirzepatide may provide enhanced support for appetite control, insulin sensitivity, and body composition management
Potential benefits may include:
Enhanced appetite suppression
Metabolic optimization
Weight management support
Improved insulin sensitivity
Support for long-term wellness goals
Potential Side Effects may include:
Nausea (most common, especially early)
Decreased appetite
Constipation or diarrhea
Fatigue
Note: These products alone are not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not GLP-1 medications could be appropriate for you.
Frequently Asked Questions
Still have questions? Take a look at the FAQ or reach out anytime. If you’re feeling ready, go ahead and apply.
-
· Most users notice appetite changes within the first week.
-
Clinical data shows most individuals regain a significant amount of lost weight within 1 to 2 years of discontinuation. Sustainable lifestyle changes during treatment improve long-term outcomes.
-
· Eat smaller, more frequent meals; avoid fatty or greasy foods; stay hydrated; eat slowly; and avoid lying down immediately after eating. Nausea typically improves after 4–8 weeks at each dose level.If appropriate, a licensed provider may recommend peptide‑supported wellness strategies as part of your plan.
-
Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide targets only GLP-1 receptors. Head-to-head trials (SURPASS-2) show tirzepatide produces greater weight loss and HbA1c reduction at all doses compared to semaglutide 1 mg weekly.
-
· : If fewer than 4 days (96 hours) have passed since the missed dose, administer it immediately. If more than 4 days have passed, skip the missed dose and resume your regular weekly schedule. Do not double dose.
-
· Rapid weight loss typically involves some lean mass reduction. <Hl>Studies suggest 25-40% of weight lost with tirzepatide may be lean mass. </Hl> Adequate protein intake (1.2-1.6 g/kg body weight) and resistance exercise are strongly recommended to preserve muscle during treatment.
-
Item descriptioEating smaller, more frequent meals, avoiding high-fat foods, staying well hydrated, and eating slowly all help reduce nausea. If symptoms are severe, extending the titration schedule or temporarily reducing the dose may provide relief. Most nausea improves as the body adjusts.